NCT00076115View on ClinicalTrials.gov

Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

December 31, 2005

Conditions
Bipolar Disorder
Interventions
DRUG

Risperidone

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00076115 - Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents | Biotech Hunter | Biotech Hunter